2,271
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients

, , , , , , , & show all
Pages 622-630 | Received 02 Jan 2018, Accepted 03 Mar 2018, Published online: 25 Apr 2018